# GSK to pull blood cancer drug from US market after study failure

- Link: https://www.widthness.com/gsk-to-pull-blood-cancer-drug-from-us-market-after-study-failure/
- Published: 2022-11-29T09:15:26-06:00
- Author: Curated by Theresa Wysocki

Photo caption: A GSK building in London. Photo courtesy of GSK. Article by Ned Pagliarulo. BioPharma Dive – November 22, 2022. GSK will pull a blood cancer drug from the U.S. market after the treatment failed in a confirmatory clinical trial, the British drugmaker announced Tuesday. Following a request from the Food and Drug Administration, GSK has begun the process of withdrawing its approved multiple myeloma therapy Blenrep. […] Click here to view original web page at www.biopharmadive.com